Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

AEON

AEON Biopharma (AEON)

AEON Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AEON
DateTimeSourceHeadlineSymbolCompany
1:35PMiHub NewswireFeaturedEzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion
01/07/20256:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AEONAEON Biopharma Inc
01/06/20259:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
01/06/20256:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AEONAEON Biopharma Inc
12/20/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
11/14/20245:05PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AEONAEON Biopharma Inc
11/13/20244:08PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:AEONAEON Biopharma Inc
11/13/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
10/07/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
09/04/20249:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AEONAEON Biopharma Inc
09/04/20249:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AEONAEON Biopharma Inc
09/04/20249:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AEONAEON Biopharma Inc
08/22/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AEONAEON Biopharma Inc
08/21/20244:26PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AEONAEON Biopharma Inc
08/12/20244:20PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:AEONAEON Biopharma Inc
08/12/20244:15PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]AMEX:AEONAEON Biopharma Inc
08/12/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
08/12/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AEONAEON Biopharma Inc
08/06/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
08/06/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AEONAEON Biopharma Inc
08/05/20244:34PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:AEONAEON Biopharma Inc
07/29/20244:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:AEONAEON Biopharma Inc
07/23/20244:43PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:AEONAEON Biopharma Inc
06/14/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
05/31/20244:03PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:AEONAEON Biopharma Inc
05/24/20248:02PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AEONAEON Biopharma Inc
05/16/20244:27PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
05/14/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AEONAEON Biopharma Inc
05/14/20249:15AMEdgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]AMEX:AEONAEON Biopharma Inc
05/14/20249:14AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AEONAEON Biopharma Inc
 Showing the most relevant articles for your search:AMEX:AEON